Systemic or hepatic blockage of RANKL signaling in mice significantly improves hepatic insulin sensitivity and promotes normalization of BGL in type 2 diabetes mellitus mouse models [42]. The gene discussed is TNFSF11; the disease is type 2 diabetes mellitus.